The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries
Open Access
- 9 April 2017
- journal article
- review article
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2017, 1-6
Abstract
Objectives. The objectives of this study were to identify the randomised controlled trials in breast cancer occurring in low and middle income countries (LMICs) generally and within Sub-Saharan Africa specifically, to describe the current status and identify opportunities for further research in these areas. Materials and Methods. Data for this study were obtained from ClinicalTrials.gov. The search term “Breast Cancer Research” was used, and relevant information extracted and analysed. Results. 2414 trials were identified, of which 1099 were eligible for inclusion. 69 of these trials occurred in LMICs. Of the 52 LMICs globally, 30% were participating in breast cancer research. Of the 17 LMICs in Africa, 77% are situated in Sub-Saharan Africa; 23% were participating in breast cancer research, which accounted for 9% of total Sub-Saharan African studies. Conclusion. This study provides current evidence for the need for breast cancer research in LMICs globally and within Sub-Saharan Africa. Within LMIC regions where research is active, the type and numbers of studies are unevenly distributed. High quality research within such areas should be encouraged as the results may have both local and global applications, particularly in the provision of affordable health care.Keywords
This publication has 10 references indexed in Scilit:
- Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer MedicineJournal of Global Oncology, 2016
- Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care?Journal of Global Oncology, 2015
- Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income CountriesPLOS ONE, 2015
- Breast cancer survival in African-American women by hormone receptor subtypesBreast Cancer Research and Treatment, 2015
- Corruption in health-care systems and its effect on cancer care in AfricaThe Lancet Oncology, 2015
- Pricing in the Market for Anticancer DrugsJournal of Economic Perspectives, 2015
- The need to expand global access to radiotherapyThe Lancet Oncology, 2014
- Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysisThe Lancet Oncology, 2013
- NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroupBreast Cancer Research and Treatment, 2012
- Developing a global strategy for cancerEuropean Journal of Cancer, 1999